NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1194729467 M.D.
Verify on CMS → Frank Tomao, M.D.
Hematology & Oncology Physician in New Hyde Park, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
186
Medicare Part D claims · 40 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
84.5/100
▲ 1 pts above national avg 83.5 · Above neutral
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Frank Tomao, M.D. reported a CMS MIPS final score of 84.5/100 - above the 83.5 national average - and filed 186 Medicare Part D claims in 2023.
- 84.5/100
- MIPS score · +1 vs avg
- 186
- Part D claims, 2023
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1194729467 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-INLINE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1194729467
- ENUM-LEGACY 2005
- TAX-MID 11K Hematology &
- MIPS-INLINE 84.5/100
- RX-LIGHT 186
- BOOK-LIGHT 967 in New York
- PHOTO-FINISH Mohammad Abu Zaid · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Tomao · this pro…
Tomao · this provider
84.5 MIPS pts
- Jing-Mei Hsu · h…
Jing-Mei Hsu
84.5 MIPS pts
- Mohammad Abu Zai…
Mohammad Abu Zaid
84.5 MIPS pts
- Ahmad Al-Homsi ·…
Ahmad Al-Homsi
84.5 MIPS pts
- Mina Gendy · near
Mina Gendy
84.5 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Frank Tomao, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
85 ≥ 42nd percentile 42% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Frank Tomao, M.D. sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Frank Tomao, M.D. writes more Part D claims than 16% of them and scores higher on MIPS quality than 40% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Frank Tomao, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Frank Tomao, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Frank Tomao, M.D.?
Near national averagePrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
186 78% vs specialty avg
MIPS final score
84.5/100 1 pts vs avg
Specialty distribution in New York
How Hematology & Oncology Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Frank Tomao, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 84.5/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1194729467 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/02/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
84.4744
Final Score
Measured-score avg: 83.5
93.334
Quality
54.914
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Frank Tomao, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
New York University
New York, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Frank Tomao, M.D.. To verify Frank Tomao, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Frank Tomao, M.D. - brand share 11.0%
Hematology & Oncology Physician average
11% brand-name claims vs 89% generic, on 186 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
186
Total Claims
$8K
Total Drug Cost
40
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 404
- Total Day Supply
- 11,360
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $2K
- Generic Drug Cost
- $6K
- Opioid Claims
- 14 (7.5% rate)
Patient Demographics
- Average Patient Age
- 79.7 years
- Avg HCC Risk Score
- 1.59
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Frank Tomao, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
42 claims
- Letrozole
Letrozole
35 claims
- Prochlorperazine M…
Prochlorperazine Maleate
23 claims
- Exemestane 13
Exemestane
13 claims
- Hydromorphone Hcl 13
Hydromorphone Hcl
13 claims
- Alprazolam 11
Alprazolam
11 claims
| Drug | Claims |
|---|---|
| Anastrozole | 42 |
| Letrozole | 35 |
| Prochlorperazine Maleate | 23 |
| Exemestane | 13 |
| Hydromorphone Hcl | 13 |
| Alprazolam | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Frank Tomao, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Frank Tomao, M.D.'s 186 claims are below the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Tomao, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (84.5 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Tomao.
One of 967 Hematology & Oncology Physician providers enrolled in New York, 5 are shown here.
Dr. Anum Aamir
M.D
Astoria, NY
Dr. Robert Abderhalden
MD
Painted Post, NY
Dr. Mohammad Maher Abdul Hay
MD
New York, NY
Dr. George Abraham
MD
Rochester, NY
Dr. Avram Abramowitz
M.D.
Fresh Meadows, NY
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Frank Tomao, M.D.'s specialty? ▼
Frank Tomao, M.D. specializes in Hematology & Oncology Physician and practices in New Hyde Park, New York. Credentials: M.D..
How much does Frank Tomao, M.D. prescribe under Medicare Part D? ▼
In 2023, Frank Tomao, M.D. wrote 186 Medicare Part D claims totaling $8K in drug costs for 40 beneficiaries.
What is Frank Tomao, M.D.'s Medicare quality score? ▼
Frank Tomao, M.D. has a CMS MIPS Final Score of 84.5/100 (Quality: 93.3, Cost: 54.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Frank Tomao, M.D. located? ▼
Frank Tomao, M.D. is located at 1999 MARCUS AVE, New Hyde Park, NY, 11042. Phone: (516) 883-0122.
What is Frank Tomao, M.D.'s NPI number? ▼
Frank Tomao, M.D.'s National Provider Identifier (NPI) is 1194729467, issued on 06/02/2005.
Does Frank Tomao, M.D. prescribe more brand-name or generic drugs? ▼
Frank Tomao, M.D.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $2K in brand drug costs.
Does Frank Tomao, M.D. prescribe opioids? ▼
Yes, Frank Tomao, M.D. had 14 opioid claims in 2023 with an opioid prescribing rate of 7.5%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Frank Tomao, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Frank Tomao, M.D.'s most frequently prescribed drugs include Anastrozole, Letrozole, Prochlorperazine Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Frank Tomao, M.D. accept Medicare? ▼
Frank Tomao, M.D. appears in CMS Medicare data with 186 Part D claims and 40 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Frank Tomao, M.D.'s credentials? ▼
Frank Tomao, M.D.'s NPI is 1194729467 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.